Three juries have determined that glyphosate, the active ingredient in the herbicide Roundup, is a carcinogen. These verdicts are in agreement with the International Agency for Research on Cancer, which concluded that glyphosate is likely to cause cancer, and other scientific studies that have linked glyphosate to the disease. However, recently published research focusing on Roundup's “inert” ingredients suggests that there may be more to it than glyphosate.

Prominent mediation attorney Kenneth Feinberg – best known as architect of the 9/11 Victims Compensation Fund – recently told the German news magazine WirtschaftsWoche (“Economic Week”) that mediation between Bayer AG and U.S. glyphosate plaintiffs is progressing – but don't look for a settlement or resolution anytime soon.

In the latest blow to German-based conglomerate Bayer, the government of Germany itself has now announced that it will begin phasing out allowed uses of glyphosate, the active ingredient in the controversial herbicide Roundup.

Is Bayer having buyer's regret over its recent acquisition of Monsanto? It should be. For the third time in less than a year, a jury has awarded a hefty amount to plaintiffs who claim they developed non-Hodgkin's lymphoma (NHL) from using the glyphosate-based herbicide, Roundup.

The plaintiffs in the most recent case were a married couple from the San Francisco area, both of whom are in their 70s and were diagnosed with NHL. They reported having used Roundup for 35 years and were diagnosed within four years of each other.